Granville Life Sciences
We provide business development strategy support for biotech, private equity, and preclinical life science companies
Our Approach
Granville Life Sciences partners with leading biotechnology and pharmaceutical innovators to accelerate the development and commercialization of transformative therapies and technology. We specialize in bringing data-driven strategy, market insight, and business development expertise to support growth across the life sciences sector.
Our foundation is built on rigorous analysis and deep scientific understanding, and we have expanded to deliver a full suite of services spanning indication prioritization, strategic partnerships support, R&D operations, and regulatory insight. At our core, we are committed to delivering clarity, precision, and measurable impact for our clients.
30+ Therapeutics Programs Evaluated
Across strategy, diligence, and development
Focus in Oncology & Advanced Modalities
Cell therapy, RNA, vaccines, and platform technologies
Senior-Led, Hands-On Engagement Model
Founder- and partner-led work on every engagement
“Granville helped us clarify our go-to-market strategy, identify the right partners, and align our internal capabilities with our growth goals. They checked every box we were hoping for in a strategic partner.”
— Director of Business Development, Biotech Client